14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of FNCH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Finch Therapeutics Group, Inc. stock price on Wednesday moving 16.89% between high and low
(Updated on Apr 24, 2024)

Sell candidate since Apr 24, 2024 PDF

The Finch Therapeutics Group, Inc. stock price fell by -17.53% on the last day (Wednesday, 24th Apr 2024) from $2.79 to $2.30. During the last trading day the stock fluctuated 16.89% from a day low at $2.25 to a day high of $2.63. The price has fallen in 6 of the last 10 days and is down by -6.12% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -537 thousand shares and in total, 117 thousand shares were bought and sold for approximately $269.64 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.52% during the next 3 months and, with a 90% probability hold a price between $1.80 and $2.78 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

FNCH Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Finch Therapeutics Group, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.52 and $2.53. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 16, 2024, and so far it has fallen -25.81%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Finch Therapeutics Group, Inc. stock

Finch Therapeutics Group, Inc. finds support from accumulated volume at $2.24 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.380 between high and low, or 16.89%. For the last week the stock has had daily average volatility of 16.42%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (FNCH) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Finch Therapeutics Group, Inc. to open at $2.39, and during the day (based on 14 day Average True Range), to move between $1.89 and $2.71, which gives a possible trading interval of +/-$0.410 (+/-17.83%) up or down from last closing price. If Finch Therapeutics Group, Inc. takes out the full calculated possible swing range there will be an estimated 35.67% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.24 (2.61%) than the resistance at $2.52 (9.57%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Finch Therapeutics Group, Inc. stock A Buy?

Finch Therapeutics Group, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Sell candidate.

Current score: -6.945 Strong Sell Candidate Downgraded

Predicted Opening Price for Finch Therapeutics Group, Inc. of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$2.39 ( 4.06%) $2.30

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for FNCH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.77 20.58 %
R2 2.63 14.27 %
R1 2.54 10.37 %
Current price: 2.30
Support S1 2.25 -2.25 %
S2 2.16 -6.15 %
S3 2.01 -12.46 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.79 21.25 %
R2 2.69 16.96 %
R1 2.52 9.57 %
Current price 2.30
Support S1 2.24 -2.61%
S2 2.20 -4.35%
S3 2.03 -11.74%

FAQ

What is the symbol for Finch Therapeutics Group, Inc. Stock and on which exchange is it traded?
The symbol for Finch Therapeutics Group, Inc. is FNCH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Finch Therapeutics Group, Inc. Stock?
Finch Therapeutics Group, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Sell candidate.

How to buy Finch Therapeutics Group, Inc. Stock?
Finch Therapeutics Group, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Finch Therapeutics Group, Inc. Stock.

What's the current price of Finch Therapeutics Group, Inc. Stock?
As of the end of day on the Apr 24, 2024, the price of an Finch Therapeutics Group, Inc. (FNCH) share was $2.30.

What is the 52-week high and low for Finch Therapeutics Group, Inc. Stock?
The 52-week high for Finch Therapeutics Group, Inc. Stock is $16.74 and the 52-week low is $0.260.

What is the market capitalization of Finch Therapeutics Group, Inc. Stock?
As of the Apr 24, 2024, the market capitalization of Finch Therapeutics Group, Inc. is 4.478M.

When is the next earnings date for Finch Therapeutics Group, Inc.?
The upcoming earnings date for Finch Therapeutics Group, Inc. is May 08, 2024.
Click to get the best stock tips daily for free!

About Finch Therapeutics Group, Inc.

Finch Therapeutics Group. Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus. It is also developing FIN-21... FNCH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT